BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35361119)

  • 1. classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes.
    Quinn GP; Sessler T; Ahmaderaghi B; Lambe S; VanSteenhouse H; Lawler M; Wappett M; Seligmann B; Longley DB; McDade SS
    BMC Bioinformatics; 2022 Mar; 23(1):114. PubMed ID: 35361119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.
    Milioli HH; Vimieiro R; Riveros C; Tishchenko I; Berretta R; Moscato P
    PLoS One; 2015; 10(7):e0129711. PubMed ID: 26132585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models.
    Eide PW; Bruun J; Lothe RA; Sveen A
    Sci Rep; 2017 Nov; 7(1):16618. PubMed ID: 29192179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. surviveR: a flexible shiny application for patient survival analysis.
    Sessler T; Quinn GP; Wappett M; Rogan E; Sharkey D; Ahmaderaghi B; Lawler M; Longley DB; McDade SS
    Sci Rep; 2023 Dec; 13(1):22093. PubMed ID: 38086891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity.
    Cascianelli S; Barbera C; Ulla AA; Grassi E; Lupo B; Pasini D; Bertotti A; Trusolino L; Medico E; Isella C; Masseroli M
    Genome Med; 2023 May; 15(1):37. PubMed ID: 37189167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.
    Alderdice M; Richman SD; Gollins S; Stewart JP; Hurt C; Adams R; McCorry AM; Roddy AC; Vimalachandran D; Isella C; Medico E; Maughan T; McArt DG; Lawler M; Dunne PD
    J Pathol; 2018 May; 245(1):19-28. PubMed ID: 29412457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis.
    Ward S; Scope A; Rafia R; Pandor A; Harnan S; Evans P; Wyld L
    Health Technol Assess; 2013 Oct; 17(44):1-302. PubMed ID: 24088296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
    Wallden B; Storhoff J; Nielsen T; Dowidar N; Schaper C; Ferree S; Liu S; Leung S; Geiss G; Snider J; Vickery T; Davies SR; Mardis ER; Gnant M; Sestak I; Ellis MJ; Perou CM; Bernard PS; Parker JS
    BMC Med Genomics; 2015 Aug; 8():54. PubMed ID: 26297356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single sample scoring of molecular phenotypes.
    Foroutan M; Bhuva DD; Lyu R; Horan K; Cursons J; Davis MJ
    BMC Bioinformatics; 2018 Nov; 19(1):404. PubMed ID: 30400809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.
    Li X; Larsson P; Ljuslinder I; Ling A; Löfgren-Burström A; Zingmark C; Edin S; Palmqvist R
    Pathol Res Pract; 2021 Apr; 220():153379. PubMed ID: 33721619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer.
    Eilertsen IA; Moosavi SH; Strømme JM; Nesbakken A; Johannessen B; Lothe RA; Sveen A
    Cancer Lett; 2020 Jan; 469():246-255. PubMed ID: 31678167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEVEA: an interactive shiny application for Differential Expression analysis, data Visualization and Enrichment Analysis of transcriptomics data.
    Riquelme-Perez M; Perez-Sanz F; Deleuze JF; Escartin C; Bonnet E; Brohard S
    F1000Res; 2022; 11():711. PubMed ID: 36999088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer.
    Piskol R; Huw L; Sergin I; Kljin C; Modrusan Z; Kim D; Kljavin N; Tam R; Patel R; Burton J; Penuel E; Qu X; Koeppen H; Sumiyoshi T; de Sauvage F; Lackner MR; de Sousa E Melo F; Kabbarah O
    Clin Cancer Res; 2019 Jul; 25(14):4431-4442. PubMed ID: 31004000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome.
    Madden SF; Clarke C; Gaule P; Aherne ST; O'Donovan N; Clynes M; Crown J; Gallagher WM
    Breast Cancer Res; 2013; 15(4):R52. PubMed ID: 23820017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of subtype-specific breast cancer surface protein biomarkers via a novel transcriptomics approach.
    Mercatelli D; Formaggio F; Caprini M; Holding A; Giorgi FM
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34750607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor.
    Nacer DF; Liljedahl H; Karlsson A; Lindgren D; Staaf J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33971670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.
    Isella C; Brundu F; Bellomo SE; Galimi F; Zanella E; Porporato R; Petti C; Fiori A; Orzan F; Senetta R; Boccaccio C; Ficarra E; Marchionni L; Trusolino L; Medico E; Bertotti A
    Nat Commun; 2017 May; 8():15107. PubMed ID: 28561063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is gene array testing to be considered routine now?
    Paik S
    Breast; 2011 Oct; 20 Suppl 3():S87-91. PubMed ID: 22015300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.